Cuba: phase II of Abdala vaccine clinical trials in minors approved
According to a statement from the Center for Genetic Engineering and Biotechnology (CIGB), it is a study without placebo, which includes Cuban children and teenagers between 12 and 18 years of age in Camagüey.